Moderna will carry out a placebo-controlled trial of its new COVID-19 vaccine, and U.S. regulators will keep tabs on the trial, Health Secretary Robert F. Kennedy Jr. said on June 3.
“I want to address those of you who have anxieties about [the Food and Drug Administration’s] limited approval of a new mRNA COVID vaccine for high-risk populations,” Kennedy wrote on social media platform X. “Moderna has agreed to a true placebo-controlled trial of the new vaccine.”
Moderna already has a COVID-19 vaccine, called Spikevax, on the market. The new vaccine, approved by health officials on May 31, is known as mNEXSPIKE. A Moderna spokesman confirmed to The Epoch Times that mNEXSPIKE utilizes messenger ribonucleic acid (mRNA) technology, just like Spikevax, but did not answer additional questions….